Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[ACE inhibition in heart failure and compromised kidney function].

H Drexler1

  • 1Medizinische Klinik III, Universitätsklinik Freiburg.

Klinische Wochenschrift
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Basal cell carcinoma risk and solar UV exposure in occupationally relevant anatomic sites: do histological subtype, tumor localization and Fitzpatrick phototype play a role? A population-based case-control study.

Journal of occupational medicine and toxicology (London, England)·2020
Same author

[Changes to the Law on Occupational Diseases and Consequences for Medical Assessment].

Pneumologie (Stuttgart, Germany)·2020
Same author

Impact of physiologically relevant temperatures on dermal absorption of active substances - an ex-vivo study in human skin.

Toxicology in vitro : an international journal published in association with BIBRA·2020
Same author

[Rare occupational diseases].

Der Internist·2020
Same author

Evaluation of urinary selenium as a biomarker of human occupational exposure to elemental and inorganic selenium.

International archives of occupational and environmental health·2019
Same author

Is ultraviolet exposure acquired at work the most important risk factor for cutaneous squamous cell carcinoma? Results of the population-based case-control study FB-181.

The British journal of dermatology·2017

When prescribing ACE-inhibitors for heart failure patients, assess renal function. Careful dosing and diuretic withdrawal are crucial to prevent adverse effects like low blood pressure and reduced kidney function.

Area of Science:

  • Cardiology
  • Nephrology
  • Pharmacology

Context:

  • Heart failure management often involves ACE-inhibitors.
  • Patients with reduced intravascular volume activate the renin-angiotensin system.
  • This system maintains blood pressure and filtration via angiotensin II.

Purpose:

  • To evaluate the impact of ACE-inhibitors on renal function in heart failure patients.
  • To identify risks and benefits associated with ACE-inhibitor therapy in specific patient subgroups.
  • To provide recommendations for safe and effective ACE-inhibitor initiation.

Summary:

  • Sudden ACE-inhibition can decrease blood pressure and glomerular filtration rate.
  • In heart failure with chronic renal failure, ACE-inhibitors pose low risk but may have limited efficacy.

Related Experiment Videos

  • Diabetic patients face increased renal impairment risk with ACE-inhibitors.
  • Short-acting ACE-inhibitors like captopril may benefit severe heart failure patients with low blood pressure.

    • Impact:

    • Highlights the importance of individualized ACE-inhibitor therapy in heart failure.
    • Emphasizes careful patient selection and monitoring, especially regarding renal function and diabetes.
    • Recommends a cautious approach: low initial doses and temporary diuretic withdrawal to optimize outcomes and minimize renal risks.